You are here: Industry Insights > UK

News List

NICE approves Cimzia but blocks Ilumetri in treatment of psoriasis pharmafile
December 07, 2018
UK drug watchdog NICE has announced two new recommendations relating to medicines for the treatment of psoriasis, approving UCB Pharma’s Cimzia (certolizumab pegol) for use on the NHS...
UCB to invest £1 billion into UK R&D pharmafile
December 07, 2018
The Brussels-based multinational UCB will invest £1 billion into UK research and development, according to the government’s Life Sciences Sector Deal, which details public and private sector investments into Britain’s life sciences industry.
UK cancer patients waiting months for accurate diagnosis pharmatimes
December 06, 2018
Cancer patients in the UK have reported that they continue to face difficulties in receiving a timely diagnosis, according to a survey commissioned by the All.Can initiative, presented at the Britain Against Cancer conference in London.
83% in healthcare say UK will not be attractive for R&D and manufacturing post-Brexit pharmafile
December 03, 2018
As the Brexit crisis continues to spiral, new findings from GlobalData reveal that 83% of healthcare professionals in the UK believe that the country will no longer present an attractive destination
UK is among the first to meet UN targets for HIV treatment and prevention, Public Health England says pharmafile
November 30, 2018
The UK is among the first countries in the world to meet the HIV treatment targets set out by the UNAIDS 90-90-90 programme, according to a new report form Public Health England.
UK cervical cancer screening rates fall to 21-year low pharmafile
November 29, 2018
A report by NHS Digital has revealed that cervical cancer screening coverage has fallen to 71.4%, down from 72% in 2017, marking the fourth year of decline in the figures and the lowest point in 21 years.
Novartis to move UK headquarters to London pharmatimes
November 29, 2018
Novartis is moving its UK headquarters to London, in a multi-million pound investment in UK life sciences, which will be complete by January 2020.
Cobra, Pall, Cell and Gene Therapy Catapult Win £1.5M Innovate UK Grant contractpharma
November 27, 2018
Cobra Biologics has won a £1.5m shared grant from Innovate UK, the United Kingdom’s innovation agency. Co-winners, Pall Corporation and the Cell and Gene Therapy Catapult will work with Cobra Biologics to investigate continuous manufacturing of adeno-asso
New UK drug pricing deal promises faster medicines access pharmaphorum
November 27, 2018
The UK government has reached a new five-year medicines pricing deal with the pharma industry to replace the almost 60-year-old Pharmaceutical Price Regulation Scheme (PPRS).
Pennsylvania Uni brings Penn Medicine to London pharmatimes
November 26, 2018
Penn Medicine has launched its first European presence in London, in a move that aims to expand access to innovations pioneered by its physicians in the US to patients in the UK and Europe.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 29 30 Next page